| 000 | 01624 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518053908.0 | ||
| 264 | 0 | _c20200806 | |
| 008 | 202008s 0 0 eng d | ||
| 022 | _a1098-6596 | ||
| 024 | 7 |
_a10.1128/AAC.01007-19 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTrinh, T D | |
| 245 | 0 | 0 |
_aMulticenter Study of the Real-World Use of Ceftaroline versus Vancomycin for Acute Bacterial Skin and Skin Structure Infections. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _c11 2019 |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCephalosporins _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSkin _xmicrobiology |
| 650 | 0 | 4 |
_aSkin Diseases, Bacterial _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVancomycin _xtherapeutic use |
| 650 | 0 | 4 | _aCeftaroline |
| 700 | 1 | _aJorgensen, S C J | |
| 700 | 1 | _aZasowski, E J | |
| 700 | 1 | _aClaeys, K C | |
| 700 | 1 | _aLagnf, A M | |
| 700 | 1 | _aEstrada, S J | |
| 700 | 1 | _aDelaportes, D J | |
| 700 | 1 | _aHuang, V | |
| 700 | 1 | _aKlinker, K P | |
| 700 | 1 | _aKaye, K S | |
| 700 | 1 | _aDavis, S L | |
| 700 | 1 | _aRybak, M J | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 63 _gno. 11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.01007-19 _zAvailable from publisher's website |
| 999 |
_c29998942 _d29998942 |
||